Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Folt

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Discovery Medicine|December 17, 2013
Mechanisms and treatments for renal artery stenosisSteven T Haller, Kaleigh L Evans, David A Folt, et al.
Current Atherosclerosis Reports|October 11, 2014
Endovascular versus medical therapy for atherosclerotic renovascular diseaseMark Shipeng Yu, David A Folt, Christopher A Drummond, et al.
Southern Medical Journal|April 2, 2022
Do Interviews Really Matter in Generating Programs and Applicants' Rank Lists for the Match?Christopher Di Felice, Pallavi Sharma, David A Folt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2014
Use of renin-angiotensin inhibitors in people with renal artery stenosisKaleigh L Evans, Katherine R Tuttle, David A Folt, et al.
Kidney International|October 4, 2016
Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressureSteven T Haller, Sivarajan Kumarasamy, David A Folt, et al.
Journal of the American Society of Hypertension : JASH|June 9, 2015
Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosisDavid A Folt, Kaleigh L Evans, Sravya Brahmandam, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Discovery Medicine|December 17, 2013
Mechanisms and treatments for renal artery stenosisSteven T Haller, Kaleigh L Evans, David A Folt, et al.
Current Atherosclerosis Reports|October 11, 2014
Endovascular versus medical therapy for atherosclerotic renovascular diseaseMark Shipeng Yu, David A Folt, Christopher A Drummond, et al.
Southern Medical Journal|April 2, 2022
Do Interviews Really Matter in Generating Programs and Applicants' Rank Lists for the Match?Christopher Di Felice, Pallavi Sharma, David A Folt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2014
Use of renin-angiotensin inhibitors in people with renal artery stenosisKaleigh L Evans, Katherine R Tuttle, David A Folt, et al.
Kidney International|October 4, 2016
Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressureSteven T Haller, Sivarajan Kumarasamy, David A Folt, et al.
Journal of the American Society of Hypertension : JASH|June 9, 2015
Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosisDavid A Folt, Kaleigh L Evans, Sravya Brahmandam, et al.
Pageof 1